Evidence map›Paper›PMID 28405879›Full record

ArticleEndocrine2017

Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.

Francesco Fallo, Isabella Castellano, Celso E Gomez-Sanchez, Yara Rhayem, Catia Pilon, Valentina Vicennati, Donatella Santini, Valeria Maffeis, Ambrogio Fassina, Paolo Mulatero and 2 more

Open access · greenAbstract read
In one paragraph

Article in Endocrine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Primary Aldosteronism: State-of-the-Art Review.American journal of hypertension · 2022
    Article
  8. Review
  9. Primary aldosteronism - a multidimensional syndrome.Nature reviews. Endocrinology · 2022
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Advances in adrenal tumors 2018.Endocrine-related cancer · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Francesco FalloClinica Medica 3, Department of Medicine, University of Padova, Padova, Italy. francesco.fallo@unipd.it.ORCID http://orcid.org/0000-0002-7511-0226
Isabella CastellanoDivision of Pathology, Department of Medical Sciences, University of Torino, Torino, Italy.
Celso E Gomez-SanchezEndocrine Section, G.V. (Sonny) Montgomery VA Medical Center and University of Mississipi Medical Center, Jackson, MS, USA.
Yara RhayemMedizinische Klinik und Poliklinik IV, Klinikum der Ludwig-Maximilians-Universität, Munich, Germany.
Catia PilonClinica Medica 3, Department of Medicine, University of Padova, Padova, Italy.
Valentina VicennatiEndocrinology Unit, University of Bologna, Bologna, Italy.
Donatella SantiniPathology Unit, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Valeria MaffeisCytopathology Unit, Department of Medicine, University of Padova, Padova, Italy.
Ambrogio FassinaCytopathology Unit, Department of Medicine, University of Padova, Padova, Italy.
Paolo MulateroDivision of Internal Medicine and Hypertension, Department of Medical Sciences, University of Torino, Torino, Italy.
Felix BeuschleinMedizinische Klinik und Poliklinik IV, Klinikum der Ludwig-Maximilians-Universität, Munich, Germany.
Martin ReinckeMedizinische Klinik und Poliklinik IV, Klinikum der Ludwig-Maximilians-Universität, Munich, Germany.
University of Padua · ITLMU Klinikum · DEUniversity of Bologna · ITUniversity of Turin · ITG.V. (Sonny) Montgomery VA Medical Center · US

Funding

Tracking and Evaluation CoreU54GM115428 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI MASON, SARAH · 2016 to 2025
$38.2M
ROLE OF MINERALOCORTICOIDS IN LOW-RENIN HYPERTENSIONR01HL027255 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI GOMEZ-SANCHEZ, CELSO ENRIQUE · 1985 to 2017
$3.9M
Fondo Investimenti Ricerca di Base (FIRB) Accordi di Programma 2011, RBAP1153LS-02 from the Ministry of Education, University, and Research- Rome RBAP1153LS-02National Heart, Lung and Blood Institute grant R01 HL27255 and the National Institute of General Medical Sciences of the National Institutes of Health, USA 1U54GM115428NHLBI NIH HHS R01 HL027255NIGMS NIH HHS U54 GM115428
6 · The paper itself

Abstract

purposeAldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion are reported in an increasing number of patients. Five aldosterone-producing adenomas from patients with primary aldosteronism and subclinical hypercortisolism were examined. THE AIMS OF OUR STUDY WERE: (1) to analyze pathological features and immunohistochemical expression of CYP11B1 (11β-hydroxylase) and CYP11B2 (aldosterone synthase) in these tumors; (2) to investigate somatic mutations involved in adrenal steroid hypersecretion and/or tumor growth.

methodsArchival micro-dissected paraffin-embedded slides from tumor specimens were used for histological and molecular studies. Immunohistochemistry was performed using monoclonal anti-CYP11B1 and anti-CYP11B2 antibodies. Cellular composition was determined by examining for known features of zona fasciculata and zona glomerulosa, and immunoreactivity for CYP11B1 and CYP11B2 by McCarty H-score. Spot regions for mutations in KCNJ5, ATP1A1, ATP2B3, CACNA1D, PRKACA, and CTNNB1 gene sequences were evaluated.

resultsFour APAs showed a predominant (≥50%) zona fasciculata-like cell pattern: one tumor had CYP11B1 H-score = 150, no detectable CYP11B2 expression, and harbored a PRKACA p.Leu206Arg mutation (that we have reported previously elsewhere), one had no CYP11B1 expression, CYP11B2 H-score = 40, and no mutations; the remaining two adenomas had high CYP11B1 H-score (160 and 240, respectively) and low CYP11B2 H-score (30 and 15, respectively), with the latter harboring a CTNNB1 p.Ser45Phe activating mutation. One of five aldosterone-producing adenomas had a predominant zona glomerulosa-like pattern, CYP11B1 H-score = 15, CYP11B2 H-score = 180, and no mutations.

conclusionsThe majority of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion were composed mainly of zona fasciculata-like cells, while CYP11B1 and CYP11B2 immunostaining demonstrated clear heterogeneity. In a subset of cases, different somatic mutations may be involved in hormone excess and tumor formation.

Indexed as

AdenomaAdrenal GlandsAdrenocortical AdenomaAdultAgedAldosteroneBiomarkers, TumorCytochrome P-450 CYP11B2FemaleHumansHydrocortisoneHyperaldosteronismImmunohistochemistryMaleMiddle AgedSteroid 11-beta-HydroxylaseAldosteroneBiomarkers, TumorCytochrome P-450 CYP11B2HydrocortisoneSteroid 11-beta-HydroxylaseAldosterone-producing adenomaHistopathologySubclinical hypercortisolism

Identifiers

PMID28405879
PMCPMC5638684
OpenAlexW2606853105

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.